Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps

This study is looking for ways to help people with high-risk colon polyps get their follow-up colonoscopies on time. High-risk polyps mean you have a higher chance of getting colorectal cancer (CRC), which can be prevented if these polyps are found and removed. The study will test different approaches, including standard care, reminders through your electronic health record (EHR), and scheduling reminders. The goal is to see if these interventions can increase the number of people who complete their surveillance colonoscopy within 3.5 years. We are looking for patients aged 21 and older who have been diagnosed with high-risk polyps in the past 5 years. The study is currently unclear on its status.

Study design
This interventional study plans to enroll 1680 participants. It compares standard care to different communication interventions aimed at improving colonoscopy surveillance.
What's involved
Some participants will complete a 20-30 minute interview. Others will receive standard care or various communication interventions like reminders and scheduling assistance.
Compensation
Not stated in the trial record.
Follow-up
The study will track completion of surveillance colonoscopy for up to 3.5 years and implementation quality for up to 3 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06376565

Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps

Recruiting
NAAges 21+InterventionalScreening
Jonsson Comprehensive Cancer Center
~1,680 participants
Updated 2025-11-14 on ClinicalTrials.gov
What's tested:Best PracticeCommunication InterventionInterview

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Stakeholder perspectives on the multilevel intervention (Aim 1)
Measured over At time of interview
+3 more outcomes measured
Colorectal Carcinoma
1 sites across 1 states
California1
  • Folasade P May · PRINCIPAL_INVESTIGATOR · UCLA / Jonsson Comprehensive Cancer Center

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

AIM 1 PATIENTS: Patients between age 45 and 75 with a HRN diagnosis in the past 5 years
AIM 1 PATIENTS: 12 patients who did and 12 patients who did not have surveillance colonoscopy
AIM 1 PROVIDERS: Primary care providers (PCPs) and gastroenterologists (GIs)
AIM 1 ADMINISTRATORS: Administrators who are involved in care processes related to CRC screening, HRN surveillance, and/or colonoscopy scheduling
AIM 2: Patients age 45 to 75 diagnosed with a HRN during the pre-specified two-year HRN diagnosis period

Exclusion

AIM 2: Individuals with a personal history of colorectal carcinoma (CRC), inflammatory bowel disease (Crohn's, ulcerative colitis), or polyposis syndrome
AIM 2: HRN cases not confirmed by chart review (human-in-the-loop)
  • Stakeholder perspectives on the multilevel intervention (Aim 1)At time of interview

    The Investigators will conduct 1-on-1 in-depth interviews with patients, advocates, providers, and administrators. these interviews will provide data in closer proximity to intervention implementation to optimize composition, timing, and acceptability of each component. Interview content is guided by the multiple health outcomes framework (MHOF) and addresses major barriers (patient, provider, system) to surveillance and challenges (patient, provider, system) to the planned implementation of intervention components.

  • Completion of surveillance colonoscopy (Aim 2)At 3.5 years

    Will analyze rates during the study period using a generalized linear mixed model with a logit link that includes an indicator for study arm and random effects for clinic and primary care provider to account for the multilevel data structure.

  • Implementation quality (Aim 3a)Up to 3 years

    The Investigators will assess implementation quality and outcomes through stakeholder interviews (patients, providers, administrators) and chart reviews. The information gained will guide adaptations of the intervention for future use so that clinicians maximize effectiveness, feasibility, acceptability, sustainability, and impact. Findings will also determine the resources needed to successfully scale the intervention to different settings

  • Cost effectiveness (Aim 3b)Up to 3 years

    Will use standard cost-effectiveness techniques (including time discounting) to conduct an incremental cost-effectiveness analysis, measuring the Incremental Cost-Effectiveness Ratio of the natural language processing-based electronic health record intervention compared to usual care office outreach.